---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-007553"
form_type: "8-K"
ticker: "AHCO"
cik: "0001725255"
company_name: "AdaptHealth Corp."
filed_at: "2025-02-25T23:59:59+00:00"
generated_at: "2026-05-26T04:49:49.278108+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# AdaptHealth reports FY2024 net income of $90.4M vs prior year loss; revenue up 1.9%

## Summary
- FY2024 net revenue $3.261B (+1.9% YoY); net income attributable $90.4M vs net loss $678.9M.
- Adjusted EBITDA $688.7M (+2.7% YoY); cash flow from ops $541.8M, free cash flow $235.8M.
- Q4 net revenue $856.6M (-0.2% YoY); net income $50.3M vs loss $254.5M; adjusted EBITDA $200.6M.
- FY2025 guidance: net revenue $3.22B-$3.36B; adjusted EBITDA $670M-$710M; free cash flow $180M-$220M.
- Reached definitive agreement to sell certain incontinence assets in Wellness at Home segment.

## SEC filing metadata
- accession: 0001628280-25-007553
- form_type: 8-K
- ticker: AHCO
- cik: 0001725255
- company_name: AdaptHealth Corp.
- filed_at: 2025-02-25T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1725255/000162828025007553/0001628280-25-007553-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1725255/000162828025007553/ahco-20250225.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-007553
- JSON: https://secwatch.observer/filing/0001628280-25-007553.json
- Plain text: https://secwatch.observer/filing/0001628280-25-007553.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.